UNSPSC 51282530: Cefazedone sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C18H14CL2N5O5S3.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 658X66LF6Y. European Medicines Agency schedules cefazedone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01106MIG. The term cefazedone sodium is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule cefazedone sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFAZEDONE SODIUM remains US FDA's Preferred Term for this commodity. Cefazedone sodium bears US NLM identifiers UMLS ID C0140149 and NCI Concept Code C98216. SMILES: CC1NNC(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4CC(C(=O)C(C4)CL)CL)SC2)C(=O)[O-].[NA+].

UNSPSC 51282530 Cefazedone sodium is a Commodity code representing a specific pharmaceutical active ingredient, though recent state and local procurement activity under this code shows little direct alignment with cefazedone procurement itself. The solicitations tagged to this code instead reflect broader pharmaceutical supply and medical countermeasure purchasing by state health departments and county public health agencies — including antibiotic tablets, naloxone, and drug deactivation systems procured through open competitive bidding and cooperative purchasing vehicles such as MMCAP Infuse.

State and local health agencies — particularly state departments of public health and county health departments — drive activity under this code tier. The Illinois Department of Public Health and Seminole County, Florida appear as recent active buyers. Recent opportunities include the Illinois Department of Public Health's award to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through an IFB process (contract total $2,999,999.11 over three years with renewal options), and Seminole County's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, initial two-year term plus one-year renewal option, and response deadline of July 26, 2023. Illinois and Florida account for the recent visible activity; the source does not support characterization of broader geographic spread or identify additional recent opportunities under this specific code.